Shilong Lu

机构：Guangxi University of Chinese Medicine

发表论文 8 篇 · 总被引 58 次 · h-index 3

代表论文

• Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway (2017 · International Journal of Molecular Medicine · 被引 43)
• Tenascin-C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the β-catenin pathway (2023 · International Urology and Nephrology · 被引 9)
• Notoginsenoside R1 Protects against Diabetic Nephropathy through TXNIP-NLRP3 Signaling Pathway (2023 · Clinical Complementary Medicine and Pharmacology · 被引 3)
• Alterations in the TGF‐B Signaling Pathway in Human Head and Neck Squamous Cell Carcinoma (2004 · Otolaryngology · 被引 2)
• 08:00 AM: Alterations in the PI3K/AKT Pathway in Head and Neck Cancer (2006 · Otolaryngology · 被引 1)
• Correction: Tenascin‑C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the β‑catenin pathway (2026 · International Urology and Nephrology)